(19)
(11) EP 0 463 644 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
19.11.1992 Bulletin 1992/47

(43) Date of publication A2:
02.01.1992 Bulletin 1992/01

(21) Application number: 91116072.9

(22) Date of filing: 25.07.1987
(51) International Patent Classification (IPC)5A61K 49/00, G01R 33/28
(84) Designated Contracting States:
AT BE CH DE ES FR GB GR IT LI LU NL SE

(30) Priority: 04.08.1986 US 893136
27.08.1986 US 900930
15.06.1987 US 57709

(62) Application number of the earlier application in accordance with Art. 76 EPC:
87110801.5 / 0258616

(71) Applicant: NYCOMED SALUTAR, INC.
Sunnyvale, California 94086 (US)

(72) Inventors:
  • Kraft, Karl F., c/o Salutar Inc.
    Sunnyvale, CA 94086 (US)
  • Quay, Steven Carl, c/o Salutar Inc.
    Sunnyvale, CA 94086 (US)
  • Rocklage, Scott M.
    Los Gatos, CA 95032 (US)
  • Worah, Dilip M.
    Menlo Park, CA 94025 (US)

(74) Representative: Cockbain, Julian, Dr. et al
Frank B. Dehn & Co. Imperial House 15-19 Kingsway
London WC2B 6UZ
London WC2B 6UZ (GB)


(56) References cited: : 
   
     
    Remarks:
    This application was filed on 20 - 09 - 1991 as a divisional application to the application mentioned under INID code 60.
     


    (54) Use of chelate complexes


    (57) The disclosure provides the use of a physiologically compatible chelate complex of a chelating compound and a paramagnetic ion of a lanthanide element having an atomic number in the range 57 to 70 or of a transition metal having an atomic number selected from 21 to 29, 42 and 44 and of a non-paramagnetic organic calcium salt for the preparation of a magnetic resonance imaging contrast medium by admixture of said complex and said organic salt. The admixed calcium serves to enhance the biotolerability of the paramagnetic chelate containing MRI contrast medium.





    Search report